Is Cellectar Biosciences, Inc. (CLRB) a Buy, Sell, or Hold?
NASDAQ : CLRB
Cellectar Biosciences, Inc. — Analyst Ratings
$2.6 USD
$0.06 (2.24%)
- Volume
- 29.92K
- Average Volume
- 1.07M
- Market Capitalization
- $20.77M
- P/E Ratio
- -0.35
- Dividend Yield
- 0.00%
- Price Target
- $11.00
- Year High
- $6.52
- Year Low
- $2.20
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.90
Analyst Consensus Summary
Consensus Rating
Sell
8 Analysts
Rating Score
2/5
Recommendation Strength
Upside/Downside
-76.4%
vs Current Price
Price Target
$11.00
Average TargetPrice Target Range
Lowest Target
$11.00
-76.4% DOWNSIDE
Average Target
$11.00
Median Estimate
Highest Target
$11.00
-76.4% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 8
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 7 | 1 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Roth Capital | Jonathan Aschoff | $11 | $3.4225 | 2026-05-05 10:54 AM | 221.4% |
| Oppenheimer | Jeff Jones | $12 | $3.635 | 2024-03-28 03:33 AM | 230.1% |